About usSign in

RBC Capital Partners

Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
  • Finland
  • Sweden
  • Norway
  • Iceland
  • Denmark
  • Estonia
  • Latvia
  • Lithuania
Investment stages
  • Seed
  • Series A
Industries
  • Marketplaces
  • Consumer Health
  • Consumer Tech
  • BioTech
  • Enterprise
  • DigitalHealth
About
RBC Capital Partners provides junior Capital to Canadian and U.S. based midmarket companies across a wide range of industries. The firm focuses on structured cash flow term loans, subordinated debt, and mezzanine financing opportunities to support growth, acquisitions, financial sponsor buyouts, and other transformational events. The team consists of experienced professionals with significant expertise in mezzanine investment and merchant banking. RBC Capital Partners works closely with RBC senior debt partners to offer comprehensive financing solutions.
Min check size
$10K
Max check size
$1M
Fund size
NPS

Investment Thesis

RBC Capital Partners actively seeks structured cash flow term loan, subordinated debt, and mezzanine financing opportunities to provide flexibility in cash flow management and a costeffective alternative to raising additional Equity to finance transformational events, including growth Capital, acquisitions, buyouts, and more.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Motif Neurotech

Precision Neuroscience

Sensorium Therapeutics

iLoF

Alena

Rejuveron Life Sciences

OccamzRazor

CereGate

OpenBCI

Kanna Health

Neumora Therapeutics

Blackrock Neurotech

TRIPP

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp